– USA, MN – Pelvital, a privately held medical technology company focused on women’s health, announced the appointment of Lydia Zeller as CEO effective April 1, 2022, succeeding co-founder and founding CEO Dale Wahlstrom who will continue as Executive Chair on the board of directors.
“This leadership transition occurs during a period of positive momentum for Pelvital as we mark one year into our commercialization. Lydia is uniquely qualified for this role as an entrepreneurial leader who brings strong digital health experience and impressive achievements in transforming and scaling an organization. Under her leadership and vision, Pelvital can expand its reach, to help more people through solutions that are based on our novel mechanotherapy technology platform,” said Executive Chair, Dale Wahlstrom.
About Lydia Zeller
Lydia Zeller joins Pelvital from Kiio, a B2B2C provider of digital musculoskeletal healthcare. As Kiio’s President and CEO, she raised funds, drove revenue, and led the company through a period of rapid growth culminating in the acquisition by a leading digital health company. Before serving as Kiio’s CEO, Lydia Zeller held a variety of leadership roles at Kiio. As VP of Product Strategy, she handled product, sales, and marketing, landing contracts with national payers, increasing consumer adoption, and growing Kiio to national recognition as a proven player in digital musculoskeletal care. As Director of Patient Engagement Solutions, she conceptualized and operationalized the company’s pivot from clinical hardware/software sold to provider systems to a digital therapeutic sold to health insurance companies and large employers and provided as a covered benefit to their members. Before Kiio, Lydia was a co-founding associate at a niche wealth management firm where she led operations and later consulted in financial regulatory compliance. Lydia earned a BA and Executive MBA from the University of Wisconsin-Madison.
“I am thrilled to lead the Pelvital team and continue to advocate for improved access to healthcare,” said Lydia Zeller. “I have a passion for women’s health, rooted in a conviction that women deserve safe, effective, convenient solutions that respect their busy lives. As a healthcare community, it is imperative that we come together to advance health equity and address unmet needs. Pelvital has a tremendous opportunity to improve the quality of life for millions of women through the simple and efficient at-home treatment of Flyte.”
About Pelvital
Pelvital is a privately held medical technology company focused on women’s health. Pelvital’s vision is to significantly improve the lives of people who suffer from pelvic floor disorders through novel, evidence-based, easy-to-use products offered directly to consumers and in partnership with clinicians. Founded in Minnesota in 2016 with roots in Norway, the company is focused on expanding conservative treatment options.
Pelvital’s first product, Flyte, is a clinically proven, in-home treatment for pelvic floor muscle strengthening and bladder control. Paired with expert education and encouragement from our on-staff pelvic floor physical therapists or our partners, Flyte is the proven effective, simple solution for women who want to treat at home and improve their quality of life.
For more information: https://flytetherapy.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
